Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Multiple Sclerosis-Associated Uveitis in Persian Population, a Multicenter Study Publisher Pubmed



Anvari P1 ; Fekri S2 ; Hedayatfar A1, 3 ; Heidari H4 ; Hosseini S5 ; Khamesi S1 ; Kohandel K4 ; Mahdizad Z6 ; Soheilian M2 ; Zarei M6 ; Niktinat H6 ; Ebrahimiadib N7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Ophthalmology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran
  4. 4. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, 32611, FL, United States

Source: Multiple Sclerosis and Related Disorders Published:2024


Abstract

Purpose: To report the characteristics of multiple sclerosis-associated uveitis (MSU) among the Persian population. Patients and methods: Retrospective, nonrandomized, multicenter study. Epidemiological characteristics, ocular and neurologic findings, angiographic features, and visual outcomes in MSU were studied. Results: 92 patients (173 eyes) were included; the mean age at the time of uveitis onset was 35.9 ± 10.9 years (range; 10–60 years), 84.8 % were female, and 88.0 % had bilateral involvement. The anatomical subgroups were isolated anterior uveitis (AU) in 12.0 %, intermediate uveitis (IU) with or without AU in 84.8 % and pure retinal vasculitis in 3.3 % of patients. None of the patients were defined as having posterior or panuveitis. Uveitis had an insidious onset and chronic course in 89.1 % patients and was of granulomatous type in 81.9 %. The diagnosis of MS precedes uveitis onset in 48.8 % patients (range 1 to 35 years, median: 7 years) and was concurrent or after the uveitis onset in 52.2 % patients (range; 1 to 12 years; median: 2 years). Undifferentiated intermediate uveitis was the most common initial diagnosis (30.4 %) before MS establishment. 89.1 % of patients received at least one conventional immunotherapy agent. Peripheral retinal perivascular leakage (81.4 %) and optic disc hyperfluorescence (74.4 %) were the two most common fluorescein angiography (FA) findings The major causes of visual impairment were cataracts (52.7 %), cystoid macular edema (CME) (31.5 %), and optic neuritis (29.2 %). During an average follow-up time of 4.76 ± 3.18 years (range: 1–12 years), visual acuity improved –0.09 logMar/year and most eyes maintain relatively good visual acuity. Conclusion: MSU usually presents as chronic granulomatous bilateral IU and less often isolated AU, especially in females. Retinal vasculitis can be a prominent feature. Clinically, it may resemble Undifferentiated intermediate uveitis . In geographical areas where MS is prevalent, the indication of neuroimaging should be expanded and include patients presenting with chronic granulomatous IU or AU especially if accompanied by retinal vasculitis. © 2024 Elsevier B.V.
Other Related Docs
11. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)